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Amitriptyline eliminates calculi through urinary tract smooth
muscle relaxation.
Background. We investigated the effects of amitriptyline in
the urinary tract smooth muscle and urolithiasis.
Methods. Cats presenting with obstructive acute renal fail-
ure (ARF) received amitriptyline, and renal function and sur-
vival rates were analyzed. Isometric contractions and membrane
potentials of rat, pig, or human isolated urinary tract smooth
muscle were recorded in the presence or absence of amitriptyline.
Results. Twenty cats with obstructive ARF caused by urethral
plugs received amitriptyline. In all cases, plugs were completely
eliminated, and renal function returned to normal, with a 100%
survival rate in the follow-up. Amitriptyline produced potent
relaxations in rat urethral strips, accompanied by significant
reductions in urethral ring membrane potential. This effect was
prevented by pretreatment of urethral rings with 4-aminopyri-
dine (4-AP), a voltage-dependent potassium channel blocker.
Amitriptyline abolished in a reversible manner acetylcholine-,
bradykinin-, and KCl-induced contractions in rat isolated blad-
der, and this effect was also prevented by 4-AP. Of interest,
spontaneous and KCl-induced contractions of pig and human
isolated ureter were also blocked by amitriptyline.
Conclusion. Our results indicate that amitriptyline is an ef-
fective and potent relaxant of urinary tract smooth muscle and
this effect is mediated by opening of voltage dependent–potas-
sium channels. We suggest that amitriptyline administration
may help to promote elimination of urinary calculi.
Urolithiasis clinical presentations range from painful
self-limited crises to urinary flow obstruction with conse-
quent hydronephrosis and renal failure [1, 2]. Despite
the high prevalence and costs involved, pharmacologic
management of the disease has not evolved in the last
years [3–5]. Hydration, analgesic, and antispastic drugs
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have been used during crises in order to relief symptoms
and eliminate the calculi. However, a considerable num-
ber of patients experience pain for a long period of time,
and invasive modalities of treatment are sometimes nec-
essary to solve the problem [6–9]. The discovery of drugs
effective in treating calculus-induced urinary flow ob-
struction would certainly decrease costs, hospitalization
time, and complication rates secondary to extracorporeal
shock wave lithotripsy and surgery.
Anecdotal reports show that the tricyclic antidepres-
sive amitriptyline is able, in some cases, to induce the
extrusion of urinary calculi of considerable dimensions [10].
Furthermore, preliminary data from our and other labo-
ratories suggest that amitriptyline could increase the
elimination urinary calculi in an animal model of recur-
rent cystitis (Achar et al, unpublished data) [11]. Thus,
we investigated the role of amitriptyline in obstructive
acute renal failure (ARF) induced by urethral plugs in
a model of cat urolithiasis. As exciting results were pro-
duced, we then analyzed possible mechanisms of action
of amitriptyline in the urinary tract of different animal
species.
In the present study, we demonstrated for the first
time that amitriptyline was able to completely reverse
established obstructive ARF in cats, and this effect was
mediated by urinary tract smooth muscle relaxation trig-
gered by voltage-dependent potassium channel opening.
These results suggest that amitriptyline might have a
beneficial role in the treatment of urolithiasis manifesta-
tions, helping to promote calculus elimination and pain
relief.
METHODS
In vivo studies
Male cats presenting at a veterinarian hospital with
advanced obstructive ARF received amitriptyline (Pro-
dome, 1 mg/kg orally). Animals were treated for 30 days,
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an arbitrary period of time set in order to prevent com-
monly observed recurrence of obstruction. Calculus elimi-
nation, renal function, and survival rates were evaluated.
Urinalysis, plug composition analysis, serum creatinine,
and blood urea nitrogen (BUN) measurement were per-
formed by the use of commercially available kits (LAB-
TEST Diagnostics, Vista Alegre, Minas Gerais, Brazil).
In vitro studies
Electrophysiologic studies (EPS). Rat urethral rings
were everted, placed in a 2 mL perfusion chamber, and
superfused at a rate of 3 mL min1 with Krebs solution
(pH 7.4, 37C, aerated with 5% CO2, 95% O2). Micro-
pipettes (borosilicate glass capillaries, 1B120F-6, World
Precision Instruments, Sarasota, FL, USA) were made
by means of a horizontal puller (Narishige model PN3,
Tokyo, Japan) and filled with 2 mol/L KCl (tip resistance,
20 to 40 M and tip potential 6 mV). The microelec-
trodes were mounted in silver/silver chloride half-cells
on a micromanipulator (Leitz, Leica, Wetzlar, Germany)
and connected to an electrometer (Intra 767, World Pre-
cision Instruments). The urethral rings were initially equili-
brated for 1 hour. After this period of time, urethral im-
palements were carried out. The electrical signals were
continuously monitored on an oscilloscope (54645A, Hew-
lett Packard, Palo Alto, CA, USA) and recorded in a
potentiometric chart recorder (2210, LKB-Produkter
AB, Bromma, Sweden). The successful implantation of
the electrode was evidenced by a sharp drop in voltage
upon entry into a cell, minimal change (10%) in micro-
electrode resistance, and a stable potential (3 mV) for
at least 1 minute after impalement, and a sharp return
to zero upon exit from the cell. Membrane potential
measurements were obtained in Krebs solution before
and after use of 1 pmol/L amitriptyline, in the absence and
in the presence of one of the following drugs: 1 mmol/L
glybenclamide, 1 mmol/L apamin, 1 mmol/L charybdo-
toxin, 1mmol/L chlotrimazole, and 1 mmol/L 4-amino-
pyridine (4-AP). Amitriptyline and potassium channels
blockers were added to the preparations 10 and 20 min-
utes before the impalements, respectively.
Isometric contraction recordings
Adult male Wistar rats (250 to 300 g) were sacrificed
and urethra and bladder were removed. Adult pigs were
anesthetized and middle ureteral segments were ob-
tained. Human normal ureteral rings were obtained from
healthy kidney donors. Institutional Ethic’s Committee
approval and patient’s informed consent for the use of
the ureter segments were obtained. Tissue specimens
were excised and immediately placed in a Krebs solution.
Organ samples were carefully freed from fat and connec-
tive tissue. Isolated organ preparations (urethral and
bladder strips, and ureteral rings) were mounted for iso-
metric recording in 5 mL chambers containing Krebs
solution (supplemented with 1 mmol/L BaCl2 when ana-
lyzing pig ureteral rings) maintained at 37C and bubbled
with a gaseous mixture of O2 (95%) and CO2 (5%). Prepa-
rations were submitted to optimal tensions (rat urethra
and bladder, and human ureter, 1 g; and pig ureter, 4 g)
and equilibrated for 1 hour. Tension was recorded
through SCANS 60.106A Acquisition System and pro-
cessed by the software Proto-5 (Letica, Barcelona, Spain).
Concentration-response [1 nmol/L to 1 mmol/L acetyl-
choline (ACh)] or single (for 80 mmol/L KCl or 1mol/L
bradykinin) curves were carried out in rat bladders in
the absence or presence of amitriptyline (100 nmol/L
to 10 mol/L). Human and pig spontaneous ureteral
contractions were recorded also in the absence or pres-
ence of increasing concentrations of amitriptyline. The
effect of KCl-induced contractions was also addressed
in those preparations. In order to investigate the role
of voltage-dependent potassium channels, experiments
were repeated in the presence of 4-AP or vehicle.
Statistical analysis
All data are expressed as means SEM. Comparisons
between groups were analyzed with the Student t test (for
two groups) or one-way analysis of variance (ANOVA),
followed by the Newman-Keuls test when indicated (for
three or more conditions). P 0.05 was considered statis-
tically significant. For EPS, when more than one im-
palement was performed on the same preparation, mea-
surements were averaged and considered as one.
RESULTS
In this study, 20 male cats presenting with obstructive
ARF received amitriptyline for 30 days. Blood and uri-
nary alterations observed demonstrate the severity of
the disease in those animals (Fig. 1 and Table 1). Due to
the poor outcome usually observed in these cases [12, 13]
and to our initial positive data, experiments were carried
out without the inclusion of a placebo-controlled group.
Calculus elimination was observed and urinary flow was
restored in all animals. A survival rate of 100% and, as
can be seen in Figure 1, complete reversal of renal dysfunc-
tion was observed in all cases following amitriptyline ad-
ministration. These effects were achieved in a period of
time no longer than 72 hours. No major amitriptyline-
related adverse effect was detected. Slight and transient
somnolence was seen in more debilitated animals. Resto-
ration of renal function coincided with disappearance of
such side effect.
In order to identify possible mechanisms of action for
amitriptyline, rat urethral strips were mounted in organ
baths for isometric contraction recordings. At this point,
we changed species as in vitro studies with cat tissues
were considered unethical by our local committee. Ami-
triptyline produced potent reductions in resting, non-
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Fig. 1. Creatinine (A) and blood urea nitrogen (BUN) (B) levels in cats
presenting with acute renal failure (ARF) secondary to urolithiasis before
and after treatment with amitriptyline (1 mg/kg of body weight/day, 30
days). *P  0.05; N  20. Analysis was also performed in five healthy
untreated cats and values obtained are presented for comparison.
Table 1. Findings from urinalysisa in 20 adult male cats presenting
at a veterinarian hospital with obstructive acute renal failure (ARF)
Abnormality Number
Hematuria 18 (90%)
Bacteriuria 14 (70%)
Leukocytes 10 (50%)
Cylindruria 6 (30%)
Struvite crystalsb 12 (60%)
Calcium oxalate crystalsb 8 (40%)
Amorphous urate crystalsb 4 (20%)
a Urine samples obtained through cystocentesis
b Similar crystal distribution was observed from plug content analysis
stimulated basal tone of rat urethra, with maximal relax-
ant responses at micromolar levels (Fig. 2A). Due to
problems during dissection of urethral tissue from adja-
cent structures (including penis bone), smooth muscle
layers, and consequently contractile apparatus integrity,
are frequently compromised, making urethral isometric
recordings poorly reproducible. Thus, to corroborate and
Fig. 2. Effects of amitriptyline (AMT) on rat isolated urethra. (A )
Representative tracing showing the effect of 1 mol/L amitriptyline on
basal rat urethral strip smooth muscle tone. Similar findings were obtained
in seven other experiments. (B ) Membrane potential was measured in
everted urethral rings under the following conditions: resting membrane
potential (RMP), after perfusion with 10 pmol/L amitriptyline in the
absence or presence of 4-aminopyridine (4-AP) (1 mmol/L), and after
oral administration of amitriptyline (gavage, 1mg/kg/day, 5 days). Each
sample represents a different animal (N  6 to 9). Data are expressed
as means  SEM. *P  0.001 vs. RMP. †P  0.001 vs. amitriptyline
perfusion. Inset: Typical tracings representing the findings depicted in (B).
extend our findings, EPS were also carried out with ure-
thral rings. Short-term perfusion with 1 pmol/L amitrip-
tyline produced marked reductions in resting membrane
potentials (Fig. 2B). It is noteworthy that ex vivo experi-
ments performed with urethras removed from animals
that received oral amitriptyline (1 mg/kg) for 5 days
demonstrated an even more intense hyperpolarization
(Fig. 2B). It has been described that amitriptyline can
block monovalent cation channels in different prepara-
tions [14–17]. Thus, we repeated the experiments with
amitriptyline in the presence of distinct potassium chan-
nel blockers. Perfused 4-AP (1 mmol/L), an inhibitor of
voltage-dependent potassium channels [18], abolished
amitriptyline-induced hyperpolarization in rat urethral
rings (Fig. 2B), while the blocker alone had a slight but
significant depolarizing effect on resting membrane po-
tentials. On the other hand, no significant modification
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Fig. 3. Effect of amitriptyline (AMT) on ace-
tylchlonine (ACh)-induced contractions on rat
bladder strips. ACh (1 nmol/L to 1 mmol/L)
cumulative curves were performed in the ab-
sence or in the presence of AMT 10 nmol/L
(A ), 100 nmol/L (B ), 1 mol/L (C ), and 10
mol/L (D). Effect of 1mol/L and 10mol/L
amitriptyline in the presence of 4-aminopyri-
dine (4-AP) (1 mol/L) (E and F ). Data are
expressed as means SEM of the percentage
of 80 mmol/L KCl-elicited contractions (N 
6 to 8). *P  0.05; **P  0.01; ***P  0.001.
of amitriptyline effect was detected following perfu-
sion of rat urethras with high- (3 mmol/L chlotrimazole
or 3 mmol/L charybdotoxin) or low- (3 mmol/L apamin)
conductance Ca2-activated potassium channel block-
ers, or with an adenosine triphosphate (ATP)-sensitive
(3 mmol/L glybenclamide) potassium channel antago-
nist (see [19] for review) (data not shown), suggesting
that amitriptyline acts on a specific potassium channel
subtype.
Since we needed confirmation of these results in func-
tional assays and we had to verify the effects of amitripty-
line in upper parts of the urinary tract, another series of
experiments was performed employing rat bladder and
pig ureteral strips. Concentration-dependent curves to
ACh were carried out in rat bladder strips mounted for
isometric tension recordings and results were expressed
as percentage of maximal response to 80 mmol/L KCl
(Fig. 3 A to D). The experiments were performed in
the absence or presence of increasing concentrations of
amitriptyline (0.01 to 10 mol/L). Amitriptyline pre-
sented a significant, noncompetitive inhibitory effect on
ACh-induced contractions (IC50  4.0 	 107 mol/L).
At 10 mol/L, amitriptyline abolished the contractile
effect of ACh. Several mechanisms of action have been
described for amitriptyline, one of them being a competi-
tive blockade of muscarinic receptors. Thus, in order to
rule out a selective anticholinergic action of amitripty-
line, receptor-dependent (bradykinin) or -independent
(80 mmol/L KCl) contractions were generated in rat
bladder strips, and amitriptyline effect was once more
addressed. Bradykinin (1 mol/L) elicited phasic con-
tractions in rat bladder, which were progressively inhib-
ited by amitriptyline in a concentration range very similar
to that necessary to block ACh-triggered responses
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Fig. 4. Effect of amitriptyline (AMT) on bra-
dykinin (BK)- or KCl-induced contractions in
rat bladder strips. Single curves to bradykinin
1 mol/L (A and B ) or 80 mmol/L KCl (C
and D ) were built in the absence or in the
presence of increasing concentrations of
amitriptyline. The action of 4-aminopyridine
(4-AP) on amitriptyline inhibitory effect is
demonstrated in (B and D). KCl data are ex-
pressed in grams of contraction and bradyki-
nin contractions expressed as percentage of
KCl response. Data represent means  SEM
(N 7). *P 0.05; **P 0.01; ***P 0.001.
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Fig. 5. Reversibility of amitriptyline (AMT) inhibitory effect on rat
bladder strips. Eighty mol/L KCl-induced contractions were recorded
in the absence and in the presence of 10 mol/L amitriptyline, and
following 1, 2, and 3 hours of repetitive medium renewal without ami-
triptyline readministration. Data are expressed in grams of contraction
and represent means  SEM (N  5). *P  0.05; **P  0.01; ***P 
0.001. Inset: Typical tracing demonstrating reversible action of amitrip-
tyline. Upward and downward arrows indicate 80 mmol/L KCl and 10
mol/L amitriptyline administration, respectively. Similar recordings
were obtained in at least five experiments.
(Fig. 4A). Surprisingly, even maximal contractions in-
duced by KCl were markedly inhibited by 10 mol/L
amitriptyline (Fig. 4C). Given that amitriptyline appeared
to be a rather nonspecific blocker of rat bladder contrac-
tions, we analyzed the reversibility of its inhibitory effect.
Rat bladders exposed for 30 minutes to 10 mol/L ami-
triptyline had their responses to KCl abolished (Fig. 5).
Preparations were then washed in Krebs solution several
times, and progressive recovery of KCl-induced response
was demonstrated. After a washout period of 3 hours,
amitriptyline effect was fully reversed, with recordings
of KCl-elicited contractions similar to those obtained
before amitriptyline administration (Fig. 5). Thus, this
series of experiments ruled out a toxic, nonreversible ef-
fect of amitriptyline in urinary tract smooth muscle. To
confirm that voltage-dependent potassium channels me-
diate amitriptyline inhibitory effect, ACh curves in the
presence of amitriptyline were repeated in preparations
preincubated with 4-AP (1 mmol/L) for 20 minutes. As
can be verified in Figure 3 E and F, 4-AP, as seen in rat
urethra, prevented amitriptyline from reducing the tonus
of rat bladder strips. In a separate series of experiments,
we ruled out a potentiating effect of 4-AP on ACh-
elicited contractions in the absence of amitriptyline (data
not shown), suggesting a specific effect of this potassium
channel blocker on amitriptyline action in the urinary
tract. The mechanism of action of amitriptyline in rat
bladder strips seemed to be the same regardless the con-
tractile agent used, as inhibition of bradykinin- and KCl-
induced contractions by amitriptyline was also prevented
by pretreatment of the preparations with 4-AP (Fig. 4 B
and D).
Fig. 6. Representative tracings of spontaneous and KCl-induced con-
tractions of pig isolated ureteral rings in the absence (A ) or in the
presence (B and C ) of 1 mol/L amitriptyline. Amitriptyline inhibitory
action was completely prevented by preadministration of 1 mmol/L
4-aminopyridine (4-AP) (D ). Similar findings were obtained in at least
five experiments.
Urinary calculi are distributed mostly along the ureter
when they are detected by image methods in the setting
of painful crises. With that in mind, we analyzed the
effects of amitriptyline in pig mid-ureteral rings mounted
for isometric tension recordings. Following the equilibra-
tion period, nonstimulated ureteral rings exhibit periodic
clusters of strong phasic contractions (Fig. 6 A and B).
This activity was not mediated by parasympathetic in-
nervation, since it could not be blocked by 1 mol/L
atropine administration (data not shown). Amitriptyline
incubation progressively inhibited the frequency and am-
plitude of these twitches, and pig ureter contractile activ-
ity was abolished in the presence of 1 mol/L amitripty-
line, a concentration ten times lower than that necessary
to block rat bladder contractile activity (Fig. 6B). Pro-
gressive renewal of Krebs solution in the absence of
amitriptyline rescued the normal phasic contraction pat-
tern observed before amitriptyline administration (data
not shown). As demonstrated in rat bladder, amitripty-
line inhibitory action was not selective for receptor-medi-
ated stimulation, as KCl-elicited contractions were also
blocked by amitriptyline in pig ureteral rings (Fig. 6 A
and C). In addition, amitriptyline negative effect on
smooth muscle tonus was also prevented by preincuba-
tion of ureteral preparations with 4-AP (Fig. 6D). Fi-
nally, in order to demonstrate that amitriptyline has a
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Fig. 7. Representative tracings of spontaneous and KCl-induced con-
tractions on human isolated ureteral rings in the absence (A and B )
or in the presence of 0.1 mol/L and 1 mol/L amitriptyline (A and C,
respectively). Amitriptyline inhibitory action was completely reversed
following medium renewal (D ) and prevented by preadministration of
1 mmol/L 4-aminopyridine (4-AP) (E ). Similar findings were obtained
in at least four experiments.
potential use in clinical practice, we investigated the ef-
fect of this drug in human isolated ureteral rings obtained
from kidney donors. As observed with pig ureter, the
preparation, in most cases, exhibits spontaneous phasic
contractions (Fig. 7). After a short period of time in
presence of 0.1 mol/L amitriptyline, this contractile ac-
tivity was partially inhibited while 1mol/L amitriptyline
completely abolished ureteral twitches (Fig. 7 A and C).
In addition, even maximal tonic contractions elicited by
80 mmol/L KCl were completely prevented by preincu-
bation of human ureter with 1 mol/L amitriptyline (Fig.
7 B and C). Furthermore, as demonstrated in rat and pig
preparations, amitriptyline inhibitory effect was reversed
by Krebs solution renewal and prevented by preincuba-
tion of the preparations with 4-AP (Fig. 7 D and E).
DISCUSSION
The discovery of drugs effective in treating urolithiasis
would be a significant step in the management of a condi-
tion for which conservative approaches have a rather
limited success rate. In fact, previous attempts to identify
beneficial agents have produced negative or modest re-
sults, and drugs such as calcium channel blockers and
nitrates, for instance, were tested in a controlled way
[20, 21] but never included in common clinical practice.
Our study is the first to demonstrate that amitriptyline,
a drug used for many years for the treatment of depres-
sion and other conditions, facilitates the elimination of
urinary calculi in felines. In the presence of urinary flow
obstruction, these animals only rarely pass the calculi
spontaneously, and obstructive ARF due to urolithiasis
in cats is accompanied by a high mortality rate, even
when invasive approaches are employed. In the present
study, 20 animals with advanced obstructive ARF that
received amitriptyline survived following passing a ure-
thral plug. The calculi elimination occurred in a period
of time no longer than 72 hours and renal function re-
turned to normal in all of them. Due to ethical issues,
we were not allowed to compare these results with those
obtained from a control group. However, comparison
with historical data [12, 13] demonstrated the marked
beneficial effect of amitriptyline in such a condition.
Urinalysis and analysis of the constitution of elimi-
nated plugs showed a varied composition, including
struvite, calcium oxalate, and amorphous urate crystals.
This finding and the rapid resolution of the obstruction
induced by the drug suggest that amitriptyline mecha-
nism of action probably would not involve a specific bio-
chemical alteration in the urine. Thus, we hypothesized that
amitriptyline could modify urinary tract smooth muscle
tone, as demonstrated previously for other types of vas-
cular and nonvascular smooth muscle preparations [22–24].
Our results in rat urethra confirmed that amitriptyline
produces potent smooth muscle relaxations that appear
to be mediated by opening of voltage-dependent potas-
sium channels. The fact that only 4-AP among five potas-
sium channel blockers was effective in inhibiting amitrip-
tyline action points to a very specific mechanism of action
for this drug. It is noteworthy that amitriptyline reduced
urethral tone even in the absence of a precontraction,
suggesting a mechanism independent of any particular
ligand pathway. In fact, experiments with rat isolated
bladder strips demonstrated that KCl-, ACh-, or brady-
kinin-elicited contractions were completely blocked by
amitriptyline through the same mechanism. This is an in-
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teresting finding since, during painful crises due to uro-
lithiasis, several mediators are probably involved in uri-
nary tract smooth muscle marked contractions that
usually accompany the case. We speculate that amitripty-
line would be effective in blocking smooth muscle tone
increases induced by most if not all of the known and
unknown contracting agents. In addition, these experi-
ments were also useful to demonstrate that amitriptyline
effect is fully reversible, ruling out a possible permanent
toxic effect as a cause for smooth muscle relaxation. The
fact that medium renewal for a period of time longer
than 3 hours was necessary to completely wash out ami-
triptyline and to obtain complete recovery of rat bladder
contractions points to a long-lasting effect of a single
dose of the drug. This would be another advantageous
characteristic for a drug to be used in the clinical setting
of urolithiasis.
Ureteral stones are the main concern when treating
patients with urolithiasis. Although we had convincing
results in rat urethra and bladder, we proceeded to stud-
ies utilizing pig isolated ureteral rings to verify if amitrip-
tyline effect would persist despite species and urinary
tract region differences. Indeed, spontaneous and in-
duced contractions were abolished by pretreatment of
pig ureter with amitriptyline. As seen for rat bladder, this
effect was not ligand-dependent, as atropine-resistant
twitches, and KCl-induced contractions were equally in-
hibited by amitriptyline. Once again, the mechanism of
action of amitriptyline was demonstrated to be depen-
dent on opening of voltage-dependent 4-AP–sensitive
potassium channels.
Since our main goal is to identify drugs potentially
useful in the management of urolithiasis, we considered
it appropriate to test amitriptyline in human isolated
preparations. Ureteral rings from normal kidney donors
mounted for isolated bath preparations presented a be-
havior very similar to that observed for pig ureter under
basal conditions. The response of human tissue samples
to amitriptyline was also comparable, and ureteral con-
tractions were prevented by the administration of micro-
molar concentrations of the drug. As described for rat
bladder and pig ureter, amitriptyline effect was also re-
versible. The potency of amitriptyline in human (as well
as pig) ureteral rings was even higher than that observed
in lower parts of the urinary tract, with spontaneous and
KCl-elicited contractions being abolished at 1 mol/L
in contrast to 10 mol/L amitriptyline necessary to pro-
duce the same effect in rat bladder. It should be empha-
sized that human ureteral contractions were quickly
eliminated by the use of amitriptyline at a concentration
within the range of steady-state plasma levels found in
patients taking low to moderate (100 mg) doses of the
drug for the treatment of depression [25–27].
CONCLUSION
We have identified for the first time a new desirable
effect and mechanism of action for a well-known drug.
Amitriptyline was found to produce potent, rapid, long-
lasting, reversible, and extremely effective blockade of
urinary smooth muscle contractions regardless the iden-
tity of the contracting agent. Due to the considerable
number of patients treated with amitriptyline in the past
decades, its pharmacokinetics and adverse effect profile
are well recognized. Taken together, these elements sug-
gest that amitriptyline is potentially a candidate to be used
in the treatment of urolithiasis-induced painful crises.
To address this hypothesis, a placebo-controlled clinical
trial is currently underway in our institution to investi-
gate the effects of short-term amitriptyline administra-
tion on calculus elimination and pain relief.
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